Advanced search×

Phenotypic Heterogeneity of Sarcomeric Gene Mutations

Luisa Mestroni

J Am Coll Cardiol 54(4):3 (2009) PMID 19608032

Copyright © 2009 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.jacc.2009.04.029
Version: za2963e q8zae q8zba q8zc0 q8zd5 q8zee q8zf4 q8zgd

Similar articles you may find interesting…

  1. Heart failure and personalized medicine.
    Luisa Mestroni, Marco Merlo, ... Gianfranco Sinagra

    J Cardiovasc Med (Hagerstown) 12(1):6-12 (2011) PMID 20814312

  2. Prognostic impact of familial screening in dilated cardiomyopathy.
    Michele M Moretti, Marco M Merlo, ... Gianfranco G Sinagra

    Eur J Heart Fail 12(9):922-7 (2010) PMID 20525703

    Between 1988 and 2007, 637 DCM patients were consecutively enrolled. Of these, 130 patients (20.4%) had FDC, including 82 (12.9%) probands and 48 (7.5%) non-proband FDC patients (NP-FDC), identified by family screening. We compared the 48 NP-FDC patients with a sample of 96 patients with sporadic DC...
  3. Development and implementation of a pharmacist-managed clinical pharmacogenetics service.
    Kristine R KR Crews, Shane J SJ Cross, ... James M JM Hoffman

    Am J Health Syst Pharm 68(2):143-50 (2011) PMID 21200062 PMCID PMC3228517

    The development and implementation of a pharmacist-managed clinical pharmacogenetics service are described. A pharmacist-managed clinical pharmacogenetics service was designed and implemented at an academic specialty hospital to provide clinical pharmacogenetic testing for gene products important to...
    View PDF